Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
106,851,987
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
72,601,582
-
Shares change
-
+3,870,697
-
Total reported value, excl. options
-
$301,915,716
-
Value change
-
+$16,703,932
-
Put/Call ratio
-
69%
-
Number of buys
-
61
-
Number of sells
-
-50
-
Price
-
$4.16
Significant Holders of MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) as of Q4 2024
140 filings reported holding MXCT - MAXCYTE, INC. - Common Stock, par value $0.01 per share as of Q4 2024.
MAXCYTE, INC. - Common Stock, par value $0.01 per share (MXCT) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72,601,582 shares
of 106,851,987 outstanding shares and own 68% of the company stock.
Largest 10 shareholders include CADIAN CAPITAL MANAGEMENT, LP (9,344,424 shares), BlackRock, Inc. (8,023,440 shares), VANGUARD GROUP INC (5,429,681 shares), Vitruvian Partners LLP (5,043,356 shares), MORGAN STANLEY (4,408,253 shares), MIRABELLA FINANCIAL SERVICES LLP (3,700,000 shares), RIVER GLOBAL INVESTORS LLP (3,253,192 shares), Mudita Advisors LLP (3,223,407 shares), FMR LLC (3,136,771 shares), and MILLENNIUM MANAGEMENT LLC (2,740,871 shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.